ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2610

The Role of IL-20 in the Pathogenesis of Ankylosing Spondylitis with Peripheral Joint Involvement

Göksal Keskin1, Baris Mavi2, Lale Ozisik3, Rahsan Ilikci4 and Mehmet Yildiz2, 1Immunology, Medical School of Ankara, Ankara, Turkey, 2Internal Medicine, Diskapi Training and Research Hospital, Ankara, Turkey, 3Internal Medicine, MD, Ankara, Turkey, 4Basic Immunology, BC, Ankara, Turkey

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment III

Session Type: Abstract Submissions (ACR)

Background/Purpose

The interleukin-20 (IL-20) is a pro-inflammatory cytokine of the IL-10 family and sequence amino acid is very similar. It has been reported to be involved in the pathogenesis of several autoimmune diseases, but pathophysiological importance is poorly understood.    TNF alpha plays an important role in AS patients with axial and peripheral joint involvement.  It has been reported that TNF alpha induce IL-20 in macrophage and synovial cells.   For this reason, we investigated serum IL-20 levels in AS patients with axial and peripheral joint involvement who had not received anti- TNF treatment. 

Methods

63 patients with AS (11 female, 52 male) and 17 healthy controls (2 female, 15 male; mean age 26.5 ± 6.9 years) were  enrolled in this study.  Thirty-eight of the AS patients were axial involvement (mean age; 25,9 ± 7.2 years, median disease duration 7 years) and the other 24 patients were peripheral joint involvement (mean age; 27.3 ± 6.9 years, median disease duration; 9 years).  Serum IL-20 levels were determined by ELISA.

Results

The median serum IL-20 levels were 55,2 pg/ml in healthy controls, 308.5 pg/ml in the patients with peripheral joint involvement and 109.3 pg/ml in the patients with axial involvement. Serum IL-20 levels in patients with AS were significantly higher than in healthy controls (p<0.001).  Serum IL-20 levels were significantly high in the patients with peripheral joint involvement compared with in the patients with axial involvement (p<0.001).  in the patients with peripheral joint involvement, there are statistically significant correlation between serum IL-20 and serum CRP and ESR (r=0.645, p <0.001, and r=0.588, p<0.001 respectively). In the patients with axial involvement, it was not correlated with CRP and ESR (r=0.262, p=0.298 and r=0.292, p=0.355  respectively).   

Conclusion

Serum IL-20 levels are high in the AS patients with peripheral joint involvement and, correlated with CRP and ESR. So, it may be involved in  pathogenesis of the disease.


Disclosure:

G. Keskin,
None;

B. Mavi,
None;

L. Ozisik,
None;

R. Ilikci,
None;

M. Yildiz,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-role-of-il-20-in-the-pathogenesis-of-ankylosing-spondylitis-with-peripheral-joint-involvement/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology